PROSTASPY Trademark

Trademark Overview


On Wednesday, July 15, 2020, a trademark application was filed for PROSTASPY with the United States Patent and Trademark Office. The USPTO has given the PROSTASPY trademark a serial number of 79293978. The federal status of this trademark filing is REGISTERED as of Tuesday, July 20, 2021. This trademark is owned by ABX advanced biochemical compounds - Biomedizinische Forschungsreagenzien GmbH. The PROSTASPY trademark is filed in the Pharmaceutical Products category with the following description:

medical and veterinary preparations for the diagnosis of diseases of the prostate; medical and veterinary preparations for the treatment of diseases of the prostate; medical and veterinary preparations for the diagnosis of cancer; medical and veterinary preparations for the treatment of cancer; dietetic foods and beverages for medical or veterinary purposes; chemical preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the diagnosis of cancer; chemical preparations for medical or pharmaceutical purposes for the treatment of cancer; biological preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; biological preparations...
prostaspy

General Information


Serial Number79293978
Word MarkPROSTASPY
Filing DateWednesday, July 15, 2020
Status700 - REGISTERED
Status DateTuesday, July 20, 2021
Registration Number6422408
Registration DateTuesday, July 20, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 4, 2021

Trademark Statements


Goods and Servicesmedical and veterinary preparations for the diagnosis of diseases of the prostate; medical and veterinary preparations for the treatment of diseases of the prostate; medical and veterinary preparations for the diagnosis of cancer; medical and veterinary preparations for the treatment of cancer; dietetic foods and beverages for medical or veterinary purposes; chemical preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the diagnosis of cancer; chemical preparations for medical or pharmaceutical purposes for the treatment of cancer; biological preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the diagnosis of cancer; biological preparations for medical or pharmaceutical purposes for the treatment of cancer; preparations for use in medical diagnostic processes; preparations for use in medical diagnostic processes relating to the diagnosis of diseases of the prostate; preparations for use in medical diagnostic processes relating to the diagnosis of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 18, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameABX advanced biochemical compounds - Biomedizinische Forschungsreagenzien GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressRadeberg 01454
DE

Party NameABX advanced biochemical compounds - Biomedizinische Forschungsreagenzien GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameABX advanced biochemical compounds - Biomedizinische Forschungsreagenzien GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Thursday, September 17, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 22, 2020APPLICATION FILING RECEIPT MAILED
Wednesday, October 28, 2020ASSIGNED TO EXAMINER
Wednesday, November 4, 2020NON-FINAL ACTION WRITTEN
Thursday, November 5, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, November 24, 2020REFUSAL PROCESSED BY MPU
Tuesday, November 24, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sunday, December 13, 2020REFUSAL PROCESSED BY IB
Tuesday, March 30, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 30, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 14, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 14, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Monday, April 19, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, May 4, 2021PUBLISHED FOR OPPOSITION
Tuesday, May 4, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 11, 2021NOTIFICATION PROCESSED BY IB
Friday, June 11, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, July 20, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, October 20, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, November 22, 2021GENERIC MADRID TRANSACTION CREATED
Tuesday, November 23, 2021GENERIC MADRID TRANSACTION SENT TO IB
Friday, December 10, 2021NEW REPRESENTATIVE AT IB RECEIVED
Monday, January 10, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, July 20, 2026COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED